Haleon reports US sales growth by targeting GLP-1 drug users
Haleon says it is growing US sales of consumer-health products aimed at countering side-effects of weight-loss drugs as GLP-1 use rises.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.